Skip to main navigation

Skip to main content

About Us
Overview Leadership Board of directors Scientific advisory board Corporate Responsibility Contact us
FORCE^TM Platform
Overview Scientific publications & presentations
Pipeline
Overview DYNE-101 DYNE-251 DYNE-302
Patients
Our Commitment Clinical trials DM1 stories DMD stories FSHD stories Resources
Investors & Media
Company overview News & events Stock information Corporate governance Financials & Filings IR resources
Culture & Careers
Our culture & values Hear from our dynamos Competitive benefits Open positions

Open navigation

About Us FORCE^TM Platform Pipeline Patients Investors & Media Culture & Careers

Overview
Leadership
Board of directors
Scientific advisory board
Corporate Responsibility
Contact us

about-us

Overview
Scientific publications & presentations

force™-platform

Overview
DYNE-101
DYNE-251
DYNE-302

pipeline

Our Commitment
Clinical trials
DM1 stories
DMD stories
FSHD stories
Resources

patients

Company overview
News & events
Stock information
Corporate governance
Financials & Filings
IR resources

investors--media

Our culture & values
Hear from our dynamos
Competitive benefits
Open positions

culture--careers

Stay in Touch

info@dyne-tx.com 781.786.8230
781.786.8230
linkedin.com twitter.com facebook.com youtube.com

Focused on muscle and

positioned for growth

Press Releases
Events and Presentations

Press Releases

Press Releases

2025 2024 2023 2022 2021 2020 2019 all

January 5, 2022

Dyne Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 21 - 21 of 21

Print

Contact IR

RSS

Email Alerts

Stay in touch

info@dyne-tx.com 781.786.8230
781.786.8230
linkedin.com twitter.com facebook.com youtube.com

Privacy Policy
© 2025 Dyne Therapeutics, Inc.